Developing a Risk Prediction Model for Long-Term Physical and Psychological Functioning after Hematopoietic Cell Transplantation.

Hematopoietic cell transplantation (HCT) is associated with impaired physical and psychological functioning for some long-term survivors. A risk prediction model would help clinicians estimate their patients' physical and psychological functioning after HCT and determine when to refer to added supportive care when appropriate. The purpose of the present study was to develop risk prediction models for physical and psychological functioning in HCT survivors. This was a secondary analysis of data from a randomized controlled trial (NCT00799461) that included 3- to 10-year HCT survivors. Risk predictions for physical and psychological functioning were developed by using backward logistic regression. The models were internally validated using bootstrapping techniques. Regression coefficients were converted into easy-to-use risk scores. Finally, the sensitivity, specificity, and positive and negative predictive values of the total risk score were calculated. The analyses included 489 survivors, with a mean age of 45.6 (SD, 12.4) years; 47% were female and with a mean of 6.1 years (SD, 2.0) after transplantation. Younger age, higher body mass index (BMI), no or part-time work, more comorbid diseases, autologous transplantation, and chronic graft-versus-host disease predicted impaired physical functioning. Female gender, younger age, higher BMI, not living with a partner, autologous transplantation, and chronic graft-versus-host disease predicted impaired psychological functioning. Although both models had predictive value for long-term functioning, diagnostic accuracy was moderate. For the physical functioning receiver operating characteristic, area under the curve (AUC) after internal validation was .74 with sensitivity 51.9 and specificity 82.8 at the optimal cut-off. For psychological functioning, AUC after internal validation was .69 with sensitivity 83.3 and specificity 42.9 at the optimal cut-off. We conclude that it is possible to predict long-term physical and psychological functioning with readily accessible, mostly pretransplantation predictors. The accuracy of the risk prediction models can be improved for use in clinical practice, potentially by adding pretransplantation patient-reported functioning and comorbidities.

[1]  Stephanie J. Lee,et al.  Delivering care to long-term adult survivors of hematopoietic cell transplantation. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  H. Deeg,et al.  Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality. , 2014, Blood.

[3]  A. Zander,et al.  The role of biomedical and psychosocial factors for the prediction of pain and distress in patients undergoing high-dose therapy and BMT/PBSCT , 2002, Bone Marrow Transplantation.

[4]  J. Ware,et al.  International quality of life assessment (IQOLA) project , 1992, Quality of Life Research.

[5]  J. Shults,et al.  Functional status, time to transplantation, and survival benefit of kidney transplantation among wait-listed candidates. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[6]  P. Richardson,et al.  Routine screening for psychosocial distress following hematopoietic stem cell transplantation , 2005, Bone Marrow Transplantation.

[7]  K. Syrjala,et al.  Evidence for a biopsychosocial model of cancer treatment-related pain , 1995, Pain.

[8]  Associations of calf skeletal muscle characteristics and peripheral nerve function with self-perceived physical functioning and walking ability in persons with peripheral artery disease , 2011, Vascular medicine.

[9]  J. Blanch,et al.  Role of depression as a predictor of mortality among cancer patients after stem-cell transplantation. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  D. Cella,et al.  Factors associated with self-reported physical and mental health after hematopoietic cell transplantation. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[11]  A. Zander,et al.  Cognitive function in the acute course of allogeneic hematopoietic stem cell transplantation for hematological malignancies , 2007, Bone Marrow Transplantation.

[12]  P. Jacobsen,et al.  Do Coping and Social Support Predict Depression and Anxiety in Patients Undergoing Hematopoietic Stem Cell Transplantation? , 2009, Journal of psychosocial oncology.

[13]  G. Bedogni,et al.  Clinical Prediction Models—a Practical Approach to Development, Validation and Updating , 2009 .

[14]  P. Cuijpers,et al.  Predictors of health-related quality of life in patients treated with auto- and allo-SCT for hematological malignancies , 2012, Bone Marrow Transplantation.

[15]  Stef van Buuren,et al.  Flexible Imputation of Missing Data , 2012 .

[16]  Patrick Royston,et al.  How should variable selection be performed with multiply imputed data? , 2008, Statistics in medicine.

[17]  H. Deeg,et al.  A disease risk index for patients undergoing allogeneic stem cell transplantation. , 2012, Blood.

[18]  A. Thompson Psychosocial impact of , 2009 .

[19]  Ron D Hays,et al.  Correlated physical and mental health summary scores for the SF-36 and SF-12 Health Survey, V.1 , 2007, Health and quality of life outcomes.

[20]  G. Nordström,et al.  Symptom Occurrence, Symptom Intensity, and Symptom Distress in Patients Undergoing High‐dose Chemotherapy With Stem‐cell Transplantation , 2004, Cancer nursing.

[21]  E. Estey,et al.  Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  David W. Hosmer,et al.  Applied Logistic Regression , 1991 .

[23]  J. Larson The MOS 36-Item Short form Health Survey , 1997, Evaluation & the health professions.

[24]  S. Bhatia,et al.  Adverse psychological outcomes in long-term survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study (BMTSS). , 2011, Blood.

[25]  A. Beekman,et al.  Comment on ‘Psychological distress in patients with cancer: is screening the effective solution?' , 2013, British Journal of Cancer.

[26]  L. Persson,et al.  Health-Related Quality of Life in Patients Undergoing Allogeneic Stem Cell Transplantation After Reduced Intensity Conditioning Versus Myeloablative Conditioning , 2009, Cancer nursing.

[27]  Sunil J Rao,et al.  Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2003 .

[28]  K. Syrjala,et al.  Development and implementation of an Internet-based survivorship care program for cancer survivors treated with hematopoietic stem cell transplantation , 2011, Journal of cancer survivorship : research and practice.

[29]  N. Leidy,et al.  Health-related quality of life in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation , 2006, Bone Marrow Transplantation.

[30]  E. Altmaier,et al.  Social Support, Optimism, and Self-Efficacy Predict Physical and Emotional Well-Being After Bone Marrow Transplantation , 2007, Journal of psychosocial oncology.

[31]  Kyle Steenland,et al.  A Practical Guide to Dose-Response Analyses and Risk Assessment in Occupational Epidemiology , 2004, Epidemiology.

[32]  Yvonne Vergouwe,et al.  Prognosis and prognostic research: Developing a prognostic model , 2009, BMJ : British Medical Journal.

[33]  D W Bates,et al.  Can comorbidity be measured by questionnaire rather than medical record review? , 1996, Medical care.

[34]  C. Rini,et al.  Quality of life concerns and depression among hematopoietic stem cell transplant survivors , 2011, Supportive Care in Cancer.

[35]  J E Ware,et al.  Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. , 1998, Journal of clinical epidemiology.

[36]  Vincent Mor,et al.  The psychosocial impact of cancer on older versus younger patients and their families , 1994, Cancer.

[37]  G. Winkel,et al.  Psychological distress in long‐term survivors of hematopoietic stem cell transplantation , 2008, Psycho-oncology.

[38]  Patrick Royston,et al.  Multiple imputation using chained equations: Issues and guidance for practice , 2011, Statistics in medicine.

[39]  E. Orav,et al.  Psychosocial function after hematopoietic stem cell transplantation. , 2005, Psychosomatics.

[40]  E. Steyerberg Clinical Prediction Models , 2008, Statistics for Biology and Health.

[41]  E. Anaissie,et al.  Changes in quality-of-life and psychosocial adjustment among multiple myeloma patients treated with high-dose melphalan and autologous stem cell transplantation. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[42]  M. Horowitz,et al.  Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  J. Beaumont,et al.  Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  S. Bhatia,et al.  Long-term recovery after hematopoietic cell transplantation: predictors of quality-of-life concerns. , 2010, Blood.

[45]  S. Langer,et al.  Psychometric properties of the Cancer and Treatment Distress (CTXD) measure in hematopoietic cell transplantation patients , 2016, Psycho-oncology.

[46]  B. Storer,et al.  Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  L. Robison,et al.  Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study. , 2010, Blood.

[48]  J. Blanch,et al.  Patient-rated emotional and physical functioning among hematologic cancer patients during hospitalization for stem-cell transplantation , 2005, Bone Marrow Transplantation.

[49]  S. Bhatia Long-term health impacts of hematopoietic stem cell transplantation inform recommendations for follow-up , 2011, Expert review of hematology.

[50]  P. Fayers,et al.  A prospective study of health-related quality of life, fatigue, anxiety and depression 3–5 years after stem cell transplantation , 2004, Bone Marrow Transplantation.

[51]  R. Soiffer,et al.  Quality of life associated with acute and chronic graft-versus-host disease , 2006, Bone Marrow Transplantation.

[52]  B. Storer,et al.  Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. , 2004, JAMA.

[53]  J. Pérez-Simón,et al.  Quality of life assessment in patients undergoing reduced intensity conditioning allogeneic as compared to autologous transplantation: results of a prospective study , 2004, Bone Marrow Transplantation.

[54]  E. Altmaier,et al.  Social Support and Depression among Bone Marrow Transplant Patients , 2008, Journal of health psychology.